相关实验视频

Updated: Sep 8, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

与免疫检查点抑制剂相关的皮肤毒性基于FDA不良事件报告系统2011 - 2023数据数据

Xiao-Yan Qiu, Zhang-Yong Fu, Ai-Feng Wu

    International journal of clinical pharmacology and therapeutics
    |July 22, 2025
    PubMed
    概括

    免疫检查点抑制剂 (ICI) 可以引起皮肤毒性,而抗PD-1剂的发病率和死亡率最高. 然而,抗CTLA-4疗法在皮肤不良事件中呈现出最显著的安全信号.

    更多相关视频

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

    Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

    Published on: February 10, 2023

    1.4K
    High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research09:12

    High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

    Published on: June 10, 2025

    407

    相关概念视频

    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    658